Welcome to the e-CCO Library!

P217: Prevalence of COVID-19 in IBD patients treated with infliximab and vedolizumab in Croatian tertiary center – clinical observation of a case series
Year: 2022
Source: ECCO'22
Authors: Domislović, V.(1);Brinar, M.(1,2);Čukovic-Čavka, S.(1,2);Turk, N.(1);Grgić, D.(1);Barišić, A.(1);Jelaković, M.(1);Krznarić, Ž.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P217: Risk factors of primary sclerosing cholangitis and cirrhosis in ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Z. Azizi*1, Y. Farbod2, S. Javid2, N. Ebrahimi Daryani2, V. Basirat2

Created: Friday, 22 February 2019, 9:49 AM
P217: Serological biomarkers of type VI collagen remodelling reflect endoscopically and clinically active Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Lindholm*1,2, L. E. Godskesen2, J. Kjeldsen2, A. Krag2, M. A. Karsdal1, T. Manon-Jensen1, J. H. Mortensen1

Created: Friday, 22 February 2019, 9:41 AM
P217: The relationship between thiopurine use during pregnancy and anemia in the offspring during the first year of life
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shitrit A.B.-G.*1, Granovsky-Grisaru S.2, Goldin E.3, Koslowsky B.3

Created: Wednesday, 20 February 2019, 10:36 AM
P217: Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Miard1*, V. Desfourneaux2, M. Dewitte1,3, P. Houssel-Debry3, C. Bendavid4, Y. Harnoy2, L. Siproudhis1, G. Bouguen1

Created: Thursday, 21 February 2019, 9:14 AM
P217: Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ribaldone, D.G.(1)*;Arezzo, A.(2);Cardenia, V.(3);Caviglia, G.P.(4);Abate, M.L.(4);Saracco, G.M.(4);Astegiano, M.(5);Morino, M.(4);
Created: Friday, 14 July 2023, 10:48 AM
P218 Linked colour imaging predicts the risk of the clinical relapse in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Kanmura, Y. Komaki, F. Komaki, A. Tanaka, F. Sasaki, A. Ido

Created: Thursday, 30 January 2020, 10:12 AM
P218: Accuracy of Ultrasonography in Assessing Disease Activity in Pediatric Ulcerative Colitis: Preliminary Results of a two-center study
Year: 2022
Source: ECCO'22
Authors: Marra, A.(1);Terracciano, F.(1);Bossa, F.(1);Pastore, M.R.(2);Marseglia, A.(2);Di Rodi , A.(2);Valvano, M.R.(1);Carparelli, S.(1);Ippolito, M.A.(1);D'Altilia, M.(2);Ferrara, D.(3);Esposito, F.(3);Bucci, C.(4);Perri, F.(1);
Created: Friday, 11 February 2022, 3:52 PM
P218: Assessment of the degree of intestinal destruction in Crohn's disease at the time of diagnosis
Year: 2021
Source: ECCO'21 Virtual
Authors: Hassine, A.(1);Akkari, I.(1);Mrabet, S.(1);Ben Jazia, E.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P218: It is time to grow up: readiness is associated with better outcomes in a prospective study of pediatric transition patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Nardone, O.M.(1)*;Martinelli, M.(2);De sire, R.(3);Calabrese, G.(3);Caiazzo, A.(3);Fioretti, M.T.(2);Testa, A.(3);Limansky, L.(3);Rispo, A.(3);Di Luna, I.(3);Miele, E.(2);Staiano, A.(2);Castiglione, F.(3);
Created: Friday, 14 July 2023, 10:48 AM
P218: Oral manifestations in inflammatory bowel disease patients under anti-tumour necrosis factor treatment
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Barreiro-de Acosta*1, P. Rio2, R. Ferreiro1, M. J. Bouza1, M. d. C. Pombo1, A. Lorenzo1, M. Gallas2, J. E. Dominguez-Munoz1

Created: Friday, 22 February 2019, 9:49 AM
P218: Over 30% of active flares in inflammatory bowel disease patients are associated with gastrointestinal infectious agents
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Limsrivilai1,2, Z. Saleh2, L.A. Johnson2, R.W. Stidham3, A. Waljee3, B. Gutermuth3, S. Govani3, A. Brown3, E. Briggs3, K. Rao4, P.D. Higgins5*

Created: Thursday, 21 February 2019, 9:14 AM
P218: The cost-effectiveness of biological therapy cycles in the management of Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Bolin*1, E. Louis2, E. Hertervig3

Created: Friday, 22 February 2019, 9:41 AM
P218: Venous thromboembolism in a Finnish IBD cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sairo H.1, Jussila A.*2, Collin P.1, Huhtala H.1, Oksanen P.1

Created: Wednesday, 20 February 2019, 10:36 AM
P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Fierens1, I. Van de Pavert2, M. Walentynowicz2, S. Coenen1,3, P. Geens3, E. Weyts3, L. Van Oudenhove1,4, J. Vlaeyen2, A. von Leupoldt2, G. Van Assche1,3, S. Vermeire1,3, M. Ferrante1,3, I. Van Diest2

Created: Thursday, 30 January 2020, 10:12 AM
P219: Accuracy of imaging for the preoperative measurement of the ileocolonic Crohn’s disease length: results of a prospective cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Brouquet*1, A.-S. Rangheard2, J. Ifergan2, T. Lazure3, F. Carbonnel4, C. Penna1, S. Benoist1

Created: Friday, 22 February 2019, 9:49 AM
P219: An application of artificial intelligence in Inflammatory Bowel Disease detection
Year: 2021
Source: ECCO'21 Virtual
Authors: Rasmagina, I.(1);Bakulin, I.(1);Mariya, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P219: Impact of COVID-19 pandemic in patients with a first consultation for suspected inflammatory bowel disease.
Year: 2022
Source: ECCO'22
Authors: Ramos Lopez, L.(1);Hernández, A.(1);Carrillo-Palau, M.(1);Hernández-Camba, A.(2);Alonso-Abreu , I.(1);Reygosa, C.(1);Vela, M.(2);Rodríguez, G.E.(2);González-Mendez, Y.(1);Tardillo, C.(2);Arranz, L.(2);Benítez-Zafra, F.(1);Hernández-Guerra, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P219: Inflammatory bowel disease in children is a challenging diagnosis when overlaps with coeliac disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zambrano Perez A., Shergill-Bonner R., Kiparissi F., Acton N., Lindley K., Shah N., Baycheva M.

Created: Wednesday, 20 February 2019, 10:36 AM
P219: Migraine Is Associated with the Development of Inflammatory Bowel Disease: A Nationwide, Population-Based Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lee, C.(1)*;Han, K.(2);Yu, H.(1);Kim, S.(1);Choi, K.(1);Lee, H.J.(1);Koh, S.J.(1);Im, J.P.(1);Kim, J.S.(1);
Created: Friday, 14 July 2023, 10:48 AM